Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VNDA
일자시간출처헤드라인심볼기업
2015/09/1420:00PR Newswire (US)Vanda Pharmaceuticals Announces the Appointment of General CounselNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/09/1205:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/09/1020:30PR Newswire (US)Vanda Announces Favorable Markman Ruling in Fanapt® Patent Infringement LitigationNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/09/1006:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/09/1006:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/09/0820:00PR Newswire (US)Vanda Pharmaceuticals Announces the Appointment of European General ManagerNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/08/1020:00PR Newswire (US)Vanda Pharmaceuticals to Present at the Canaccord Genuity Annual Growth ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/08/0520:00PR Newswire (US)HETLIOZ® (tasimelteon) Phase III SET and RESET Trial Results Published in The LancetNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/08/0320:00PR Newswire (US)Vanda Announces Listing of Four New Fanapt® Patents in the FDA Orange BookNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/3120:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/3005:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/3005:01PR Newswire (US)Vanda Pharmaceuticals Reports Second Quarter 2015 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/2219:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/0922:00PR Newswire (US)Vanda Pharmaceuticals to Announce Second Quarter 2015 Financial Results on July 29, 2015NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/0805:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/0805:30PR Newswire (US)HETLIOZ® Receives European Commission Approval for the Treatment of Non-24-Hour Sleep-Wake Disorder in the Totally BlindNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/0705:32Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/0303:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/07/0222:00PR Newswire (US)Vanda Announces Listing of a New HETLIOZ® Patent in the FDA Orange BookNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/2405:30PR Newswire (US)Vanda Announces Positive Results from the Relapse Prevention Study in Patients with Schizophrenia (REPRIEVE) Demonstrating th...NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/2307:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/2307:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/2307:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/2307:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/2307:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/1922:32PR Newswire (US)Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/1905:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/1300:02Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/1105:17Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2015/06/1023:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:VNDA